United Kingdom Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 5

2 Introduction 7

• 2.1 What Is This Report About? 7
• 2.2 Diabetes Care Devices Market Segmentation 7
• 2.3 Definitions of Markets Covered in the Report 8

3 Diabetes Care Devices Market, United Kingdom 10

• 3.1 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025 10
• 3.2 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2019 12
• 3.3 Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2019 13
• 3.4 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025 14
• 3.5 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 16
• 3.6 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 18
• 3.7 Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), 2019 20

4 Glucose Monitoring Market, United Kingdom 22

• 4.1 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2015-2025 22
  • 4.1.1 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 24
• 4.2 Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2025 26
  • 4.2.1 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2015-2025 28
• 4.3 Glucose Monitoring Market, United Kingdom, Average Price ($) , 2015-2025 30
• 4.4 Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), 2019 31
• 4.5 Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), 2019 32

5 Insulin Delivery Market, United Kingdom 33

• 5.1 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2019 33
• 5.2 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019 34
• 5.3 Insulin Delivery Market, United Kingdom, Revenue ($m), 2015-2025 35
  • 5.3.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 37
  • 5.3.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 39
• 5.4 Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025 41
  • 5.4.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2015-2025 43
  • 5.4.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2015-2025 45
• 5.5 Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2025 47
• 5.6 Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), 2019 48
• 5.7 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2019 49

6 Overview of Key Companies in United Kingdom, Diabetes Care Devices Market 51

• 6.1 DexCom Inc 51
  • 6.1.1 Company Overview 51
• 6.2 Medtronic Plc 51
  • 6.2.1 Company Overview 51
• 6.3 Abbott Laboratories 51
  • 6.3.1 Company Overview 51
• 6.4 Novo Nordisk AS 52
  • 6.4.1 Company Overview 52
• 6.5 Sanofi 52
  • 6.5.1 Company Overview 52
• 6.6 Eli Lilly and Co 52
  • 6.6.1 Company Overview 52
• 6.7 Ypsomed Holding AG 53
  • 6.7.1 Company Overview 53
• 6.8 F. Hoffmann-La Roche Ltd 53
  • 6.8.1 Company Overview 53

7 Diabetes Care Devices Market Pipeline Products 54

8 Financial Deals Landscape 55

• 8.1 Equity Offerings 55
  • 8.1.1 Midatech Pharma Raises USD3 Million in Private Placement of American Depositary Shares 55
  • 8.1.2 Nemaura Medical to Raise up to USD19.5 Million in Public Offering of Shares 57
• 8.2 Partnerships 58
  • 8.2.1 LifeScan Enters into Distribution Agreement with Sanvita Medical 58
  • 8.2.2 Diabeloop and ViCentra Enter into Distribution Agreement 59

9 Recent Developments 60

• 9.1 Corporate Communications 60
  • 9.1.1 Feb 27, 2020: ConvaTec Group: Non-executive director appointment 60
  • 9.1.2 Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members 60
  • 9.1.3 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 61
  • 9.1.4 Sep 09, 2019: Midatech Pharma announces directorate change 61
  • 9.1.5 Aug 19, 2019: AstraZeneca appoints Michel Demaré to its board of directors 62
  • 9.1.6 Aug 19, 2019: John McAdam appointed Chairman of ConvaTec 63
  • 9.1.7 Jul 31, 2019: Midatech Pharma: Appointment of Non-Executive Director 63
  • 9.1.8 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 64
  • 9.1.9 Jun 25, 2019: ConvaTec Group: Board Change 65
• 9.2 Financial Announcements 65
  • 9.2.1 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019 65
  • 9.2.2 Feb 14, 2020: AstraZeneca: Full-year and Q4 2019 results 66
  • 9.2.3 Feb 11, 2020: Nemaura Medical reports results and provides business update for the third quarter ended December 31, 2019 69
  • 9.2.4 Nov 11, 2019: Nemaura medical reports results and provides business update for the second quarter ended september 30, 2019 70
  • 9.2.5 Oct 24, 2019: AstraZeneca: Year-to-date and Q3 2019 results 70
  • 9.2.6 Sep 30, 2019: Midatech Pharma: Interim results for the six months ended 30 June 2019 74
  • 9.2.7 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 79
  • 9.2.8 Aug 09, 2019: Nemaura Medical reports quarterly results for first quarter ended June 30, 2019 79
  • 9.2.9 Aug 01, 2019: ConvaTec Group first half results 2019 80
  • 9.2.10 Jul 25, 2019: AstraZeneca announces H1 2019 results 87
  • 9.2.11 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update 93
  • 9.2.12 Apr 26, 2019: AstraZeneca: Q1 2019 results 95
  • 9.2.13 Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018 97
• 9.3 Government and Public Interest 98
  • 9.3.1 Nov 28, 2019: Sosei Heptares announces that the COPD treatment Ultibro Breezhaler has been included in the national reimbursement drug list in China 98
  • 9.3.2 May 21, 2019: DiaMedica Therapeutics announces formation of scientific advisory board for kidney disease 100
• 9.4 Legal And Regulatory 102
  • 9.4.1 Nov 12, 2019: OGT continues move into molecular diagnostics markets 102
  • 9.4.2 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition 102
• 9.5 Other Significant Developments 103
  • 9.5.1 Oct 21, 2019: CRISPR Therapeutics and Bayer announce an update on Casebia Therapeutics 103
  • 9.5.2 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor 103
  • 9.5.3 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 103
  • 9.5.4 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility 104
  • 9.5.5 May 09, 2019: Cellnovo announces the initiation of compulsory liquidation proceedings with cessation of business 104
• 9.6 Product News 104
  • 9.6.1 Jan 13, 2020: Artificial Intelligence (AI) can detect low-glucose levels via ECG without fingerpick test 104
• 9.7 Strategy And Business Planning 105
  • 9.7.1 Dec 17, 2019: Roche gets UK and US clearances for Spark Therapeutics acquisition 105
  • 9.7.2 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 106
  • 9.7.3 Nov 12, 2019: Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination 107

10 Appendix 108

• 10.1 Research Methodology 109
  • 10.1.1 Coverage 109
  • 10.1.2 Secondary Research 109
  • 10.1.3 Primary Research 110
  • 10.1.4 Market Modeling and Forecasting 110
  • 10.1.5 Company Share Analysis 112
  • 10.1.6 Distribution Share Analysis 112
  • 10.1.7 Benchmarking 113
• 10.2 GlobalData Consulting 113
• 10.3 Contact Us 114